Drug Profile
Cat allergy immunotherapy - Planet Biopharmaceuticals
Latest Information Update: 19 Feb 2014
Price :
$50
*
At a glance
- Originator Planet Biopharmaceuticals
- Class Allergens; Antiallergics; Cat allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypersensitivity